• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对多毛症患者的新治疗方法。

New therapeutic approach to the hirsute patient.

作者信息

Boisselle A, Tremblay R R

出版信息

Fertil Steril. 1979 Sep;32(3):276-9. doi: 10.1016/s0015-0282(16)44232-9.

DOI:10.1016/s0015-0282(16)44232-9
PMID:488407
Abstract

Spironolactone, an aldosterone antagonist currently used in the treatment of hypertension, has numerous antiandrogenic side effects. Decreased production rates of testosterone in intact (N = 10) and hirsute (N = 6) women, respectively, were noted after short (7 days) or long-term (6 months) administration of the drug, 25 mg twice daily. A 50% diminution in the urinary 17-ketosteroid excretion was also observed after 6 months of therapy. Assessment of the treatment was done by the patients: a reduction in hair growth rate was initially observed after 3 to 4 months, followed by the appearance of a more downy type of new growth and a decrease in diameter of the hair shaft. It is concluded that this beneficial effect is obtained by a decrease in the testosterone production rate and probably through competitive inhibition of spironolactone and/or canrenone with the androgen receptor in human hair follicles.

摘要

螺内酯是一种目前用于治疗高血压的醛固酮拮抗剂,有许多抗雄激素副作用。在完整女性(N = 10)和多毛女性(N = 6)中,分别在短期(7天)或长期(6个月)每日两次服用25毫克该药物后,观察到睾酮生成率降低。治疗6个月后,尿17 - 酮类固醇排泄量也减少了50%。患者对治疗进行了评估:最初在3至4个月后观察到毛发生长速度降低,随后出现更柔软的新生毛发类型,毛干直径减小。得出的结论是,这种有益效果是通过降低睾酮生成率以及可能通过螺内酯和/或坎利酮与人毛囊中的雄激素受体竞争性抑制而获得的。

相似文献

1
New therapeutic approach to the hirsute patient.针对多毛症患者的新治疗方法。
Fertil Steril. 1979 Sep;32(3):276-9. doi: 10.1016/s0015-0282(16)44232-9.
2
Spironolactone in the treatment of hirsutism.螺内酯治疗多毛症
Arch Gynecol. 1987;240(2):95-100. doi: 10.1007/BF02134041.
3
The effect of spironolactone on hirsutism and female androgen metabolism.
Clin Endocrinol (Oxf). 1985 Aug;23(2):161-7. doi: 10.1111/j.1365-2265.1985.tb00211.x.
4
Side-effects of spironolactone therapy in the hirsute woman.螺内酯治疗多毛女性的副作用。
J Clin Endocrinol Metab. 1988 Jan;66(1):208-11. doi: 10.1210/jcem-66-1-208.
5
Testosterone, 17 Ks, 17 beta E2 FSH-LH variations and hirsutism modifications during spironolactone therapy.螺内酯治疗期间睾酮、17-KS、17-β-E2、促卵泡激素-促黄体生成素的变化及多毛症的改善情况
Clin Exp Obstet Gynecol. 1984;11(1-2):49-54.
6
A novel use of spironolactone: treatment of hirsutism.
J Clin Endocrinol Metab. 1980 Sep;51(3):429-32. doi: 10.1210/jcem-51-3-429.
7
Lack of effect of spironolactone on hair shaft diameter in hirsute females.螺内酯对多毛女性毛干直径无影响。
Postgrad Med J. 1989 Jul;65(765):459-62. doi: 10.1136/pgmj.65.765.459.
8
The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women.两种剂量螺内酯对多毛症女性血清雄激素及生长期毛发的影响。
Fertil Steril. 1985 Feb;43(2):200-5. doi: 10.1016/s0015-0282(16)48373-1.
9
Spironolactone is an effective and well tolerated systemic antiandrogen therapy for Hirsute women.螺内酯是一种对多毛女性有效的、耐受性良好的全身性抗雄激素疗法。
J Clin Endocrinol Metab. 1989 May;68(5):966-70. doi: 10.1210/jcem-68-5-966.
10
[The treatment of hirsutism in adolescent girls with spironolactone].[螺内酯治疗青春期女孩多毛症]
Akush Ginekol (Sofiia). 1999;38(4):28-30.

引用本文的文献

1
Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies.5α-还原酶抑制剂和螺内酯在接受内分泌治疗的乳腺癌患者中的安全性。
Breast Cancer Res Treat. 2019 Feb;174(1):15-26. doi: 10.1007/s10549-018-4996-3. Epub 2018 Nov 22.
2
Obstetrics and gynecology-epitomes of progress: a new and effective treatment of hirsutism.妇产科学——进展缩影:多毛症的一种新的有效治疗方法
West J Med. 1981 Jun;134(6):527-8.
3
Hirsutism and the effectiveness of spironolactone in its management.
J Endocrinol Invest. 1993 Dec;16(11):925-32. doi: 10.1007/BF03348960.
4
The interaction of canrenone with oestrogen and progesterone receptors in human uterine cytosol.坎利酮与人子宫胞质溶胶中雌激素和孕激素受体的相互作用。
Br J Clin Pharmacol. 1983 Jan;15(1):95-101. doi: 10.1111/j.1365-2125.1983.tb01470.x.
5
Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutism.
J Endocrinol Invest. 1983 Feb;6(1):23-7. doi: 10.1007/BF03350556.
6
Spironolactone in the treatment of idiopathic hirsutism and the polycystic ovary syndrome.螺内酯治疗特发性多毛症和多囊卵巢综合征。
J R Soc Med. 1986 Aug;79(8):451-3. doi: 10.1177/014107688607900806.
7
Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liver.螺内酯和烯睾丙内酯对大鼠肝脏胞质及核雄激素和雌激素受体的影响。
Gastroenterology. 1987 Oct;93(4):681-6. doi: 10.1016/0016-5085(87)90428-8.
8
Alopecia and hirsuties. Current concepts in pathogenesis and management.
Drugs. 1988 Jan;35(1):83-91. doi: 10.2165/00003495-198835010-00005.
9
Lack of effect of spironolactone on hair shaft diameter in hirsute females.螺内酯对多毛女性毛干直径无影响。
Postgrad Med J. 1989 Jul;65(765):459-62. doi: 10.1136/pgmj.65.765.459.
10
Hirsutism.多毛症
BMJ. 1990 Nov 24;301(6762):1215-6.